{"_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP21CAw","type":"Investor","logokey":"$3diwdFB4DJo57wnHC7YDKgkEZOYHhCQkM6180Nkv5ANCRPnkm0Tbud","name":"Cormorant Asset Management","subtype":"Institutional Investor","lastupdate":"2024-11-25T00:00:00.000Z","update_date":"2024-11-25T00:00:00.000Z","lastModified":"Nov 25, 2024","active":1,"confidence_score":46,"confidence_score_reason":"funding stage, product stage, sector, number of employees, business model, tag line, video or image, funding rounds, news, markets, not claimed","urlname":"cormorant-asset-management","minimal_profile":0,"hide_reason":null,"status":"","fullstatus":null,"hide_reason_data":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"isisraeli":0,"country":"United States","formernames":[],"min_date_investments":"2015-12-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":null,"founded_year":2013,"iia_supported":null,"currently_iia_supported":null,"alternativenames":null,"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"https://www.cormorant.com","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/56041707","instagram":""},"social":["https://www.linkedin.com/company/56041707"],"flattenedsociallinks":"https://www.linkedin.com/company/56041707","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Cormorant Asset Management is a specialized investment firm focused on healthcare and life sciences. It invests in innovative biotechnology, pharmaceutical, and healthcare technology companies across private and public markets. The firm leverages its expertise to back growth-stage businesses, particularly those driving advancements in medical treatments and healthcare solutions. Cormorant combines venture capital and hedge fund strategies to identify high-potential opportunities in the rapidly evolving life sciences sect","founded":"1/2013","education":null,"additional_activities":null,"events":null,"techcommunityinvolvement":null,"exits":[{"date":"Mar 2021","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"MQqfvbs2FzZdL8fshJOiOfDc8i2SHcB6N5GKcMMERauqnA9EIoc0KE","mnatype":null,"eventtype":"ReverseMergerEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"Undisclosed","stockexchange":"NASDAQ","eventvisibility":null,"token_visibility":"","acquiredcompany_mna":"Chemomab Therapeutics","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","acquiredcompany_reverse":"Anchiano Therapeutics","acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgO7j_OMIDA","acquiredcompany_mna_fullurl":"/company_page/chemomab","acquiredcompany_mna_logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","acquiredcompany_mna_urlname":"chemomab","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":0,"acquiredcompany_reverse_fullurl":"/company_page/biocancell-therapeutics","acquiredcompany_reverse_logokey":"$3T7izMc6sH9yONnXrV84AfCeroSWV0kLhRIcdc5hAYPUt6TEMmo3y3","acquiredcompany_reverse_urlname":"biocancell-therapeutics","blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$AU2PTNC6m8YQhSAZinm36kCeLZigl0lwDvuFvOK4ns8LMZtmlmhlUB","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"https://storage.googleapis.com/clean-finder-353810/$3T7izMc6sH9yONnXrV84AfCeroSWV0kLhRIcdc5hAYPUt6TEMmo3y3","style":"","hiddenCompanyTooltip":""}],"funds":[],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","name":"Chemomab Therapeutics","hidden":false,"raised":"$90.5M","founded":"2011","fullurl":"/company_page/chemomab","logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","urlname":"chemomab","employees":"11-50","description":"Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases","fundingstage":"Public","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":90500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7nuZUKDA","name":"Fore Biotherapeutics","hidden":false,"raised":"$153.5M","founded":"2011","fullurl":"/company_page/novellusdx","logokey":"$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","urlname":"novellusdx","employees":"51-200","description":"Precision Oncology Treatments","fundingstage":"D","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":153500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Aug 2023","name":"Fore Biotherapeutics","amount":75000000,"hidden":false,"islead":0,"country":null,"eventid":"S6cC23rWs2rCMTBcD2HkOvPJV7pZHn4SXgedCCXXIBf3SD3NmguwyC","fullurl":"/company_page/novellusdx","logokey":"$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","tagline":"Precision Oncology Treatments","urlname":"/company_page/novellusdx","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7nuZUKDA","isfollowon":1,"companytype":"Startup","eventamount":"$75M","fundingtype":"D Round","investmentid":"LGwQ0CwLaWTeONaw2OvriQeipxUhMBWWCGVPVh3zDd79kPFUKkspS5","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Mar 2021","name":"Chemomab Therapeutics","amount":45500000,"hidden":false,"islead":1,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOC7mf29CQw","fullurl":"/company_page/chemomab","logokey":"$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","tagline":"Innovative Treatments for Patients with Fibro-Inflammatory-Related Diseases","urlname":"/company_page/chemomab","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMrEoLkKDA","isfollowon":0,"companytype":"Startup","eventamount":"$45.5M","fundingtype":"PIPE","investmentid":"b0e36149-1b89-44a4-8c84-df39be536c34","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1EZ7uaks0Xv419bkCiZfwWku4tiSvvPPsbl8YpTlL9VcKuTdAGHlRC","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Sep 2020","name":"Fore Biotherapeutics","amount":57000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCFqYSICQw","fullurl":"/company_page/novellusdx","logokey":"$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","tagline":"Precision Oncology Treatments","urlname":"/company_page/novellusdx","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN7nuZUKDA","isfollowon":0,"companytype":"Startup","eventamount":"$57M","fundingtype":"C Round","investmentid":"41b057f6-6f0e-4069-a0d3-09bd4da0d801","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$gDy9pYdc1NCNlqOf0E7cImK22EwdFWg2ndlRbBbjxMA79Z5CqsI1Vi","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2015","name":"Gelesis","amount":31500000,"hidden":true,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODkgO_ECgw","fullurl":"/foreign_startup/gelesis","logokey":"$1f751Un8Vr720EA9LQtX8YbYcZJtb90ZjuV2Tmw6fof9mYo0H1PAg0","tagline":"Orally Administered Capsule which Induces Safe Weight Loss","urlname":"/company_page/gelesis","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgPOX2ooKDA","isfollowon":null,"companytype":"Foreign Startup","eventamount":"$31.5M","fundingtype":"E Round","investmentid":"1612da25-12cb-4c22-9582-244e7a2ad742","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$1f751Un8Vr720EA9LQtX8YbYcZJtb90ZjuV2Tmw6fof9mYo0H1PAg0","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"flex","label":"Non-Israeli"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Bihua   Chen","email":"CHEN@cormorant-asset.com","phone":"","gender":"Female","userid":"rufFcSkZfufbV83Ky6wxMPkOSVm3WPAsetSVjoN0w2WhZUmFytH05m","bounced":false,"claimed":null,"founder":1,"urlname":"bihua-chen","visible":1,"memberid":"x295W6KBeQXMVStcSXuzRo02bndb8SGT1fdLRmq3zBi79nQOmRZ5LO","position":"\tFounder & CEO","last_name":" Chen","claimtoken":null,"first_name":"Bihua ","picturekey":null,"claimeddate":null,"linkedinurl":null,"unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"B ","pictureurl":"/assets/empty-state.svg","linkedin-display":"none","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Raymond  Kelleher","email":"kelleher@cormorant-asset.com","phone":"","gender":"Male","userid":"1S2lofdZPyvDWJD8Aax0ekT5lXnRKDgZJNIv7Kbkon7l9LOjIddiUl","bounced":false,"claimed":null,"founder":0,"urlname":"raymond-kelleher","visible":1,"memberid":"kkAHc1cXsiNpMjMGO7kTp1jgDx3WbDNuo1GNoLixafDykayObtOaoW","position":"Managing Director","last_name":"Kelleher","claimtoken":null,"first_name":"Raymond ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/raymond-j-kelleher-md-phd-83304799/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"RK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["life-sciences","biotechnology","medical-devices"],"targetmarkets":[],"phone":null,"address":{"israeli":[],"officesabroad":[{"id":"YQs9I6eY2XDVmvSbgN4VvYkn9UFqdqGHx0WwzDXdxz8X7vAJ7aZVnY","city":"Boston","address":"200 Clarendon St 52nd floor, Boston, MA 02116, USA","country":"United States","placeid":"ChIJY16vwAx644kR4FqKEav6uX8"}]},"headquarter_address":null,"news":[],"newsNumber":0,"mediagallery":[],"biverification":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":"Ayelet Levi Shinebox","lastupdator_email":"ayeletlevis@sncentral.org","creator":"Abigail Lyss","creator_email":"abigail.lyss@gmail.com","createdate":"2019-05-11T00:00:00.000Z","recentupdates":[{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:57:26.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Automatic","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:57:19.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Automatic","datetime":"2024-11-25 09:55:53.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:57:19.000000","last_name":"Levi Shinebox","first_name":"Ayelet"},{"email":"ayeletlevis@sncentral.org","source":"Manual","datetime":"2024-11-25 09:55:52.000000","last_name":"Levi Shinebox","first_name":"Ayelet"}],"rounds_per_sector":[{"count":3,"sector":"Health Tech & Life Sciences"},{"count":1,"sector":"Other"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"C Round"},{"count":1,"isfollowon":1,"fundingStage":"D Round"},{"count":1,"isfollowon":0,"fundingStage":"E Round"},{"count":1,"isfollowon":0,"fundingStage":"PIPE"}],"investment_rounds_over_time":[{"year":2015,"month":12,"record_count":1},{"year":2020,"month":9,"record_count":1},{"year":2021,"month":3,"record_count":1},{"year":2023,"month":8,"record_count":1}],"portfolio_companies_per_sector":[{"count":2,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2020,"month":9,"record_count":1},{"year":2021,"month":3,"record_count":1}],"exits_over_time":[{"year":2021,"count":1,"eventType":"ReverseMergerEvent"}],"exits_by_sector":[{"count":1,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":null,"timeline":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Institutional Investor","parsedName":"Cormorant Asset Management","logourl":"https://storage.googleapis.com/clean-finder-353810/$3diwdFB4DJo57wnHC7YDKgkEZOYHhCQkM6180Nkv5ANCRPnkm0Tbud","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$3diwdFB4DJo57wnHC7YDKgkEZOYHhCQkM6180Nkv5ANCRPnkm0Tbud","teamMembersNumber":2,"section":null,"sectionParams":"","queryParams":"","seoabout":"Cormorant Asset Management is a specialized investment firm focused on healthcare and life sciences. It invests in innovative biotechnology, pharmaceutical...","seoTitle":"Foreign Institutional Investor","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"C Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"D Round\",\"newInvestments\":0,\"followOnInvestments\":1},{\"fundingStage\":\"E Round\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"PIPE\",\"newInvestments\":1,\"followOnInvestments\":0}],\"investmentRoundsBySector\":[{\"count\":3,\"sector\":\"Health Tech & Life Sciences\"},{\"count\":1,\"sector\":\"Other\"}],\"investmentRoundsOverTime\":[{\"label\":\"2015\",\"count\":1},{\"label\":\"2016\",\"count\":0},{\"label\":\"2017\",\"count\":0},{\"label\":\"2018\",\"count\":0},{\"label\":\"2019\",\"count\":0},{\"label\":\"2020\",\"count\":1},{\"label\":\"2021\",\"count\":1},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":1},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":2,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2020\",\"count\":1},{\"label\":\"2021\",\"count\":1},{\"label\":\"2022\",\"count\":0},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2021,\"count\":1,\"eventType\":\"ReverseMergerEvent\"},{\"year\":2015,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2015,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2016,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2018,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2018,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2019,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2019,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2020,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2020,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2024,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2024,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":1,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"","managedAssetsNumber":null,"investmentrange":"$31.5M - $75M","communityinvolvement":[],"foreignInvestments":"","nationality":"Foreign","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}